Feature Announcements Join us on Kaysen's Quest: Learn more about Gene Therapy, Zolgensma As a company that specializes in drug information, DrugBank always tries to remain informed about novel treatments, drug approvals, and drugs that are impacting global health. At the top of our minds lately
press releases Edmonton Startup, DrugBank, Graduates from Creative Destruction Lab - West May 27, 2020 - Edmonton based startup, DrugBank, recently graduated from the 2019/20 Creative Destruction Lab (CDL) Program. CDL is a seed-stage accelerator program for massively scalable, science-based companies. Its nine-month program
White Paper UPDATED: COVID-19: Finding the Right Fit With the global outbreak of COVID-19 spanning news stations and research labs across the world, the DrugBank team put their heads together to provide an overview of current data-driven approaches to identify potential COVID-19 therapies.
In the News Cannabinoids in Epilepsy: A New Era of Treatments In a groundbreaking announcement, a Food and Drug Administration (FDA) advisory panel gave their unanimous recommendation in April 2018 for the approval of Epidiolex, a cannabis-derived product shown to be effective for the treatment of two forms of treatment-resistant childhood epilepsies.
In the News From Discovery to Resistance to Progress Progress on resistance: The discovery of malacidins, a class of chemicals made by bacteria found in soil, is an exciting advancement and will hopefully make way for near future discovery of much needed broad-spectrum antibiotics.
In the News Ketamine: the key to treatment resistant depression? The treatment of depression can be a complex blend of art and science as the pathophysiology remains poorly understood. Here we explore Ketamine, a drug that has proven to have an important place in medicine and a possibly ground-breaking place in treatment of depression.
In the News Tideglusib: From Alzheimer's to Caries Lesion Natural Repair Nowadays, it is fairly common in science to discover that a drug with an initial indication can be repurposed to target a completely different condition; this is the case with Tideglusib.
In the News CFTR Modulators Helping Cystic Fibrosis Patients Catch Their Breath Orkambi and Kalydeco are members of a new generation of medications that are making history for people living with Cystic Fibrosis. These treatments focus on improving underlying lung function rather than simply delaying its decline...
In the News New Antivirals Provide Hope for Eradication of Hepatitis C – If You Can Afford It We’ve been lucky enough to find ourselves in the golden age of antivirals. Effective medications for the management of infectious diseases like Hepatitis C and HIV have revolutionized care. Unfortunately, promises of eradication mean nothing if the drug can’t find its way into the hands of patients.
